Leicester Research Archive >
College of Medicine, Biological Sciences and Psychology >
Cell Physiology and Pharmacology, Department of >
Theses, Dept. of Cell Physiology and Pharmacology >
Please use this identifier to cite or link to this item:
|Title: ||An investigation of the mechanisms of cellular transformation by hERG potassium channels|
|Authors: ||Shehatou, George S. G.|
|Supervisors: ||Mitcheson, John|
|Award date: ||1-Jul-2011|
|Presented at: ||University of Leicester|
|Abstract: ||Human ether-à-go-go-related gene 1 (hERG1) potassium channels are expressed in a variety of tumour cells and expression of hERG1 K+ channels in normal cells can induce a transformed phenotype.
The transformative potential of hERG1 appears to be extracellular matrix-dependent. hERG1-expressing NIH-3T3 cells maintained a normal cell morphology when plated on collagen-1 and cell migration speeds were not different to those measured for empty vector-transfected NIH-3T3 cells (NIH-VC). However, hERG1-expressing NIH-3T3 cells displayed a transformed morphology and enhanced cell migration speeds when plated on laminin-1 or fibronectin, and this was associated with a reduction in vinculin protein cell content and cytoskeletal rearrangements.
I have provided evidence to indicate that the ion flux through the hERG1 pore and its cell-surface localization is important for its oncogenic potential. Unlike for wild-type hERG1, stable expression of a non-conducting G628S hERG1, or a trafficking-deficient A561V hERG1 mutant did not induce a transformed phenotype in NIH-3T3 cells. Pentamidine, a compound which inhibits hERG1 trafficking to the cell-surface, inhibited fibronectin-dependent migration of wild-type hERG1-expressing cells. Although dofetilide, which blocks the ion conductance of hERG1, did not alter the transformative effect of wild-type hERG1 expression in cell grown on fibronectin, chronic application of this hERG1 inhibitor at a therapeutically-relevant concentration (100 nM) did cause a near-complete reversion of hERG1-expressing cells to a normal cell phenotype within 14 days.
NIH-3T3 cells transiently transfected with a plasmid encoding both hERG1 and hERG1b exhibited increases in cell proliferation relative to cells expressing either isoform alone, suggesting a potential role for the hERG1b isoform in regulating hERG1 pro-oncogenic effects.
In summary, the transforming potential of hERG1 expression appears to be dependent on hERG1 trafficking to the cell-surface and its ion channel functionality. Chronic administration of hERG1-blockers may be able to impair oncogenic progression in hERG1-expressing tumours.|
|Embargo on file until: ||1-Jul-2014|
|Sponsors / Funders: ||Mansoura University, Egypt|
|Rights: ||Copyright © the author, 2011.|
|Appears in Collections:||Theses, Dept. of Cell Physiology and Pharmacology|
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.